Elevance Health, Inc. (ELV) Institutional Ownership & Insider Trading

1,600 institutions reported holding Elevance Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 22 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

ELVElevance Health, Inc.Follow ELV — free

Healthcare Plans · Healthcare

—

Price chart with a free account

Market cap: 95.1B
P/E TTM: 18.7
Dividend yield: 1.6%
52-week: —
Next earnings: 26 Jan, in 94 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,600 institutions held 94.2% of the shares. Across filers that reported both quarters, shares held changed +2.4%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,600	203	+2.4%	508	214	474	80
Mar 26	1,452	195	-2.4%	400	94	572	173
Dec 25	1,515	201	+0.3%	426	98	540	120
Sep 25	1,475	197	-2.4%	465	116	547	182
Jun 25	1,555	204	+0.5%	516	93	503	151
Mar 25	1,614	201	-1.1%	568	165	462	106
Dec 24	1,550	206	-0.4%	401	82	650	247
Sep 24	1,643	202	-3.5%	552	82	488	100

Elevance Health, Inc. — questions

Who owns Elevance Health, Inc. stock?: 1,600 institutions reported Elevance Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.8%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), STATE STREET CORP (4.8%).
Are Elevance Health, Inc. insiders buying or selling?: 22 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Elevance Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.